<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7022795/results/search/drug/results.xml">
  <result pre="evaluate the antiviral activities of four classes of antimalarial drugs:" exact="Artemisinin" post="derivatives, aryl-aminoalcohols, aminoquinolines, and antimicrobial drugs. antimalarial drugs viruses"/>
  <result pre="of the principal antimalarial drugs, divided into four main groups:" exact="Artemisinin" post="derivatives, aryl-aminoalcohols, aminoquinolines, and antimicrobial drugs. The chemical structures"/>
  <result pre="comprehensive list of published papers on the proposed field. 2." exact="Artemisinin" post="Derivatives Artemisia annua (qinghao) is a plant of the"/>
  <result pre="for ages in traditional Chinese medicine [8]. The sesquiterpene lactone" exact="artemisinin" post="(ART), the active principle, was discovered in the 1970s."/>
  <result pre="with both original research articles [10,11,12,13] and reviews [14,15]. 2.1." exact="Artemisinin" post="ART, the active principle extracted from Artemisia annua, is"/>
  <result pre="use of ART as an antiviral. ART, dihydroartemisinin (DHA) and" exact="artesunate" post="(AS) were compared for their anti-HCMV effect in a"/>
  <result pre="release in a culture medium. Moreover, synergism with the antiviral" exact="lamivudine" post="was demonstrated [17]. ART downregulated the oncogenic human papillomavirus"/>
  <result pre="effect was not reproducible in different cell models [23]. 2.2." exact="Artesunate" post="2.2.1. Artesunate and HCMV The activity of AS on"/>
  <result pre="not reproducible in different cell models [23]. 2.2. Artesunate 2.2.1." exact="Artesunate" post="and HCMV The activity of AS on the replication"/>
  <result pre="even higher than that of classical antiviral drugs, such as" exact="ganciclovir" post="[16,25,28]. The antiviral effect was confirmed against different, multidrug-resistant"/>
  <result pre="AS was synergistic with antiviral drugs such as maribavir [27,32,33]," exact="lamivudine" post="[17], ganciclovir [34], foscarnet, cidofovir, letermovir [33]. However, in"/>
  <result pre="synergistic with antiviral drugs such as maribavir [27,32,33], lamivudine [17]," exact="ganciclovir" post="[34], foscarnet, cidofovir, letermovir [33]. However, in vitro data"/>
  <result pre="iron in the Ferrosanol™ formulation [11]. AS in association with" exact="valacyclovir" post="was tested in a murine model of herpes simplex"/>
  <result pre="both drugs were higher than those of mice treated with" exact="valacyclovir" post="alone, but no significant difference was observed in the"/>
  <result pre="Interferon (IFN)-γ, and CCL2 were reduced in mice treated with" exact="valacyclovir" post="combined with ART versus those in mice treated with"/>
  <result pre="valacyclovir combined with ART versus those in mice treated with" exact="valacyclovir" post="alone [35]. Clinical data supporting the use of AS"/>
  <result pre="the other hand, a renal transplant recipient patient with documented" exact="valganciclovir" post="resistance mutations in HCMV was treated with AS, with"/>
  <result pre="the blood of children in the two groups [49]. 2.2.2." exact="Artesunate" post="and Other Viruses AS was effective at a low"/>
  <result pre="was not significant. Prospective trials are needed [60]. 2.3. Other" exact="Artemisinin" post="Derivatives The activity of different ART derivatives was evaluated"/>
  <result pre="based on transgenic viral strain. Compared to AS and/or ART," exact="artemether" post="was the most active. However, the activity was only"/>
  <result pre="HCV, showing moderate activity in the micromolar concentration range [63]." exact="Artemether" post="is often used in combination with lumefantrine. One of"/>
  <result pre="[58]. 3. Aryl-Aminoalcohols The antiviral effect of the aryl-aminoalcohol compounds" exact="quinine" post="sulfate, mefloquine, halofantrine, and lumefantrine on both classical and"/>
  <result pre="on both classical and emerging viruses has been studied. 3.1." exact="Quinine" post="Sulfate Quinine, an alkaloid extract from Chinchona (quina-quina) tree"/>
  <result pre="still playing a pivotal role, especially in the treatment of" exact="chloroquine" post="(CQ)-resistant Plasmodium falciparum [65,66]. Due to the benefit derived"/>
  <result pre="from antimalarial drugs in other pathologies, possible antiviral effects of" exact="quinine" post="were investigated. The first manuscript regarding the effect of"/>
  <result pre="quinine were investigated. The first manuscript regarding the effect of" exact="quinine" post="on influenza virus infections in mice was published in"/>
  <result pre="was published in 1946 [67]. Subsequently, in vitro evaluation of" exact="quinine" post="sulfate has been conducted with other viruses, such as"/>
  <result pre="as herpes simplex virus-1 (HSV-1) and influenza A virus (IAV)." exact="Quinine" post="sulfate at micromolar but not toxic doses reduced the"/>
  <result pre="HaCaT cell models, although no viricidal activity was observed [68,69]." exact="Quinine" post="sulfate in vitro activity was also tested against IAV"/>
  <result pre="the micromolar range, depending on the viral strains [70]. Recently," exact="quinine" post="sulfate was tested in vitro against emerging dengue virus"/>
  <result pre="3.2.1. Mefloquine and JCPyV Mefloquine (MQ), a synthetic analog of" exact="quinine" post="with a long history of use and good safety"/>
  <result pre="of the infection, with a claimed effect of MQ and" exact="mirtazapine" post="treatment [86,87,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105], and to the resolution of the infection"/>
  <result pre="difficult to determine [118,119]. MQ has also been combined with" exact="risperidone" post="[75] or risperidone and cytarabine [120], and the final"/>
  <result pre="[118,119]. MQ has also been combined with risperidone [75] or" exact="risperidone" post="and cytarabine [120], and the final outcomes were opposing,"/>
  <result pre="has also been combined with risperidone [75] or risperidone and" exact="cytarabine" post="[120], and the final outcomes were opposing, either death"/>
  <result pre="death of the patient [126]. The combined treatment MQ and" exact="mirtazapine" post="was administered to HIV-positive patients, leading to a failure"/>
  <result pre="of the three best combinations was composed of MQ with" exact="toremifene" post="(an antagonist of estrogen receptors) and the antifungal posaconazole,"/>
  <result pre="combinations was composed of MQ with toremifene (an antagonist of" exact="estrogen" post="receptors) and the antifungal posaconazole, whose activity was confirmed"/>
  <result pre="3.3. Halofantrine and Lumefantrine While good results were obtained using" exact="quinine" post="sulfate and MQ as antivirals, the same cannot be"/>
  <result pre="described in the paragraph about ART derivatives. 4. Aminoquinolines 4.1." exact="Chloroquine" post="and Hydroxychloroquine and Emerging Viruses Chloroquine (CQ) is an"/>
  <result pre="the paragraph about ART derivatives. 4. Aminoquinolines 4.1. Chloroquine and" exact="Hydroxychloroquine" post="and Emerging Viruses Chloroquine (CQ) is an aminoquinoline known"/>
  <result pre="derivatives. 4. Aminoquinolines 4.1. Chloroquine and Hydroxychloroquine and Emerging Viruses" exact="Chloroquine" post="(CQ) is an aminoquinoline known since 1934. It was"/>
  <result pre="the treatment of different diseases. Currently, CQ and its hydroxy-analog" exact="hydroxychloroquine" post="(hydroxyCQ) cannot be used as antimalarial drugs in wide"/>
  <result pre="a prophylactic advantage of CQ use was suggested [145,146,147]. 4.2." exact="Chloroquine" post="and Hydroxychloroquine and HCV CQ and its analogs have"/>
  <result pre="advantage of CQ use was suggested [145,146,147]. 4.2. Chloroquine and" exact="Hydroxychloroquine" post="and HCV CQ and its analogs have effects against"/>
  <result pre="but no results were posted due to limited recruitment. 4.3." exact="Chloroquine" post="and Hydroxychloroquine and HIV The anti-HIV-1 and anti-HIV-2 activities"/>
  <result pre="results were posted due to limited recruitment. 4.3. Chloroquine and" exact="Hydroxychloroquine" post="and HIV The anti-HIV-1 and anti-HIV-2 activities of CQ"/>
  <result pre="plasma level, although at a lower level than the antiviral" exact="zidovudine" post="[40]. In contrast, the results published in 2012 by"/>
  <result pre="no prophylaxis in HIV-positive patients in Malawi (Table 1) [44,45]." exact="Chloroquine" post="and Hydroxychloroquine and Other RNA Viruses CQ was shown"/>
  <result pre="in HIV-positive patients in Malawi (Table 1) [44,45]. Chloroquine and" exact="Hydroxychloroquine" post="and Other RNA Viruses CQ was shown to inhibit"/>
  <result pre="synthesis in virus-infected cells [164]. 5. Other Antimalarial Drugs 5.1." exact="Atovaquone" post="Atovaquone, a naphthoquinone antimalarial drug often used in pregnant"/>
  <result pre="one published work reported the in vitro antiviral action of" exact="atovaquone" post="against CHIKV. Low micromolar doses inhibited the number of"/>
  <result pre="the same paper, Kottkamp and colleagues evaluated the ability of" exact="atovaquone" post="to reduce the infectivity of both a Brazilian and"/>
  <result pre="Ugandan strain [166]. 5.2. Antimicrobial Drugs Antibiotic drugs, such as" exact="doxycycline" post="and sulfonamides, are widely used in the chemoprophylaxis of"/>
  <result pre="antiviral mechanisms of action have not been completely investigated. 5.2.1." exact="Doxycycline" post="Doxycycline (DOX) is a semisynthetic tetracycline antibiotic that prevents"/>
  <result pre="mechanisms of action have not been completely investigated. 5.2.1. Doxycycline" exact="Doxycycline" post="(DOX) is a semisynthetic tetracycline antibiotic that prevents bacterial"/>
  <result pre="been completely investigated. 5.2.1. Doxycycline Doxycycline (DOX) is a semisynthetic" exact="tetracycline" post="antibiotic that prevents bacterial protein synthesis by acting on"/>
  <result pre="subunit) [167,172,173,174,175]. DOX, widely used alone or in combination with" exact="quinine" post="for chemoprophylaxis in CQ-resistant P. falciparum cases of malaria"/>
  <result pre="agents with broad-spectrum bacteriostatic activity. Sulfonamides interrupt the synthesis of" exact="folic acid," post="interfering with the dihydropteroate synthase and dihydrofolate reductase enzymes"/>
  <result pre="authors declare no conflict of interest. Abbreviations AQ Amodiaquine ART" exact="Artemisinin" post="AS Artesunate CHIKV Chikungunya virus CQ Chloroquine DENV Dengue"/>
  <result pre="no conflict of interest. Abbreviations AQ Amodiaquine ART Artemisinin AS" exact="Artesunate" post="CHIKV Chikungunya virus CQ Chloroquine DENV Dengue virus DHA"/>
  <result pre="AQ Amodiaquine ART Artemisinin AS Artesunate CHIKV Chikungunya virus CQ" exact="Chloroquine" post="DENV Dengue virus DHA Dihydroartemisinin EC50s Effective concentrations EBV"/>
  <result pre="Human cytomegalovirus HCV Hepatitis C virus HPV Human papillomavirus hydroxyCQ" exact="hydroxychloroquine" post="IL Interleukin INF Interferon KSHV Kaposi sarcoma herpesvirus MQ"/>
  <result pre="effective and safe in rheumatic diseases?Reumatologia20185616417310.5114/reum.2018.7690430042604 3.DasA.K.Anticancer Effect of AntiMalarial" exact="Artemisinin" post="CompoundsAnn. Med. Health Sci. Res.201559310210.4103/2141-9248.15360925861527 4.WolfR.TufanoM.A.RuoccoV.GrimaldiE.RuoccoE.DonnarummaG.BaroniA.Quinine sulfate inhibits invasion"/>
  <result pre="activity of artemisinin—From bench to bedsidePlanta Med.20077329930910.1055/s-2007-96713817354163 10.EfferthT.MarschallM.WangX.HuongS.M.HauberI.OlbrichA.KronschnablM.StammingerT.HuangE.S.Antiviral activity of" exact="artesunate" post="towards wild-type, recombinant, and ganciclovir-resistant human cytomegalovirusesJ. Mol. Med.20028023324210.1007/s00109-001-0300-811976732"/>
  <result pre="recombinant, and ganciclovir-resistant human cytomegalovirusesJ. Mol. Med.20028023324210.1007/s00109-001-0300-811976732 11.KapteinS.J.EfferthT.LeisM.RechterS.AuerochsS.KalmerM.BruggemanC.A.VinkC.StammingerT.MarschallM.The anti-malaria drug" exact="artesunate" post="inhibits replication of cytomegalovirus in vitro and in vivoAntivir."/>
  <result pre="transplantationClin. Infect. Dis.2008461455145710.1086/58710618419454 13.WolfD.G.ShimoniA.ResnickI.B.StammingerT.NeumannA.U.ChouS.EfferthT.CaplanO.RoseJ.NaglerA.et al.Human cytomegalovirus kinetics following institution of" exact="artesunate" post="after hematopoietic stem cell transplantationAntivir. Res.20119018318610.1016/j.antiviral.2011.03.18421443904 14.EfferthT.RomeroM.R.WolfD.G.StammingerT.MarinJ.J.MarschallM.The antiviral activities"/>
  <result pre="after hematopoietic stem cell transplantationAntivir. Res.20119018318610.1016/j.antiviral.2011.03.18421443904 14.EfferthT.RomeroM.R.WolfD.G.StammingerT.MarinJ.J.MarschallM.The antiviral activities of" exact="artemisinin" post="and artesunateClin. Infect. Dis.20084780481110.1086/59119518699744 15.EfferthT.Beyond malaria: The inhibition of"/>
  <result pre="compoundsBiotechnol. Adv.2018361730173710.1016/j.biotechadv.2018.01.00129305894 16.FlobinusA.TaudonN.DesbordesM.LabrosseB.SimonF.MazeronM.C.SchnepfN.Stability and antiviral activity against human cytomegalovirus of" exact="artemisinin" post="derivativesJ. Antimicrob. Chemother.201469344010.1093/jac/dkt34624003183 17.RomeroM.R.EfferthT.SerranoM.A.CastañoB.MaciasR.I.BrizO.MarinJ.J.Effect of artemisinin/artesunate as inhibitors of"/>
  <result pre="on HIV-1 replicationVirus Res.201015326927610.1016/j.virusres.2010.08.01820800626 24.ZengA.H.OuY.Y.GuoM.M.DaiX.ZhouD.Z.ChenR.Human embryonic lung fibroblasts treated with" exact="artesunate" post="exhibit reduced rates of proliferation and human cytomegalovirus infection"/>
  <result pre="human cytomegalovirus infection in vitroJ. Thorac. Dis.201571151115710.3978/j.issn.2072-1439.2015.07.0526380730 25.SchnepfN.CorvoJ.PorsM.J.MazeronM.C.Antiviral activity of" exact="ganciclovir" post="and artesunate towards human cytomegalovirus in astrocytoma cellsAntivir. Res.20118918618810.1016/j.antiviral.2010.12.00221167209"/>
  <result pre="infection in vitroJ. Thorac. Dis.201571151115710.3978/j.issn.2072-1439.2015.07.0526380730 25.SchnepfN.CorvoJ.PorsM.J.MazeronM.C.Antiviral activity of ganciclovir and" exact="artesunate" post="towards human cytomegalovirus in astrocytoma cellsAntivir. Res.20118918618810.1016/j.antiviral.2010.12.00221167209 26.HeR.FormanM.MottB.T.VenkatadriR.PosnerG.H.Arav-BogerR.Unique and"/>
  <result pre="diphenyl phosphate moietyAntimicrob. Agents Chemother.2013574208421410.1128/AAC.00893-1323774439 27.ChouS.MarousekG.AuerochsS.StammingerT.MilbradtJ.MarschallM.The unique antiviral activity of" exact="artesunate" post="is broadly effective against human cytomegaloviruses including therapy-resistant mutantsAntivir."/>
  <result pre="against human cytomegaloviruses including therapy-resistant mutantsAntivir. Res.20119236436810.1016/j.antiviral.2011.07.01821843554 28.ReiterC.FröhlichT.ZeinoM.MarschallM.BahsiH.LeidenbergerM.FriedrichO.KappesB.HampelF.EfferthT.et al.New efficient" exact="artemisinin" post="derived agents against human leukemia cells, human cytomegalovirus and"/>
  <result pre="1,2,4-trioxane-ferrocene hybridsEur. J. Med. Chem.20159716417210.1016/j.ejmech.2015.04.05325965779 29.HuttererC.NiemannI.MilbradtJ.FröhlichT.ReiterC.KadiogluO.BahsiH.ZeitträgerI.WagnerS.EinsiedelJ.et al.The broad-spectrum antiinfective drug" exact="artesunate" post="interferes with the canonical nuclear factor kappa B (NF-κB)"/>
  <result pre="insights into mechanisms of ActionAntimicrob. Agents Chemother.20145898699410.1128/AAC.01972-1324277030 35.CanivetC.MenasriaR.RhéaumeC.PiretJ.BoivinG.Valacyclovir combined with" exact="artesunate" post="or rapamycin improves the outcome of herpes simplex virus"/>
  <result pre="mechanisms of ActionAntimicrob. Agents Chemother.20145898699410.1128/AAC.01972-1324277030 35.CanivetC.MenasriaR.RhéaumeC.PiretJ.BoivinG.Valacyclovir combined with artesunate or" exact="rapamycin" post="improves the outcome of herpes simplex virus encephalitis in"/>
  <result pre="Inst. Oswaldo. Cruz.201310859659910.1590/S0074-0276201300050001023903975 37.De LamballerieX.BoissonV.ReynierJ.C.EnaultS.CharrelR.N.FlahaultA.RoquesP.Le GrandR.On chikungunya acute infection and" exact="chloroquine" post="treatmentVector Borne Zoonotic Dis.2008883783910.1089/vbz.2008.004918620511 38.PatonN.I.LeeL.XuY.OoiE.E.CheungY.B.ArchuletaS.WongG.Wilder-SmithA.SmithA.W.Chloroquine for influenza prevention: A"/>
  <result pre="patients with human immunodeficiency virus type 1Clin. Ther.19951762263610.1016/0149-2918(95)80039-58565026 40.SperberK.ChiangG.ChenH.RossW.ChusidE.GoncharM.ChowR.LirianoO.Comparison of" exact="hydroxychloroquine" post="with zidovudine in asymptomatic patients infected with human immunodeficiency"/>
  <result pre="human immunodeficiency virus type 1Clin. Ther.19951762263610.1016/0149-2918(95)80039-58565026 40.SperberK.ChiangG.ChenH.RossW.ChusidE.GoncharM.ChowR.LirianoO.Comparison of hydroxychloroquine with" exact="zidovudine" post="in asymptomatic patients infected with human immunodeficiency virus type"/>
  <result pre="with human immunodeficiency virus type 1Clin. Ther.19971991392310.1016/S0149-2918(97)80045-89385480 41.PatonN.I.GoodallR.L.DunnD.T.FranzenS.Collaco-MoraesY.GazzardB.G.WilliamsI.G.FisherM.J.WinstonA.FoxJ.et al.Effects of" exact="hydroxychloroquine" post="on immune activation and disease progression among HIV-infected patients"/>
  <result pre="antiretroviral therapy: A randomized controlled trialJAMA201230835336110.1001/jama.2012.693622820788 42.JacobsonJ.M.BosingerS.E.KangM.Belaunzaran-ZamudioP.MatiningR.M.WilsonC.C.FlexnerC.ClagettB.PlantsJ.ReadS.et al.The Effect of" exact="Chloroquine" post="on Immune Activation and Interferon Signatures Associated with HIV-1AIDS"/>
  <result pre="with HIV-1AIDS Res. Hum. Retrovir.20163263664710.1089/aid.2015.033626935044 43.MurrayS.M.DownC.M.BoulwareD.R.StaufferW.M.CavertW.P.SchackerT.W.BrenchleyJ.M.DouekD.C.Reduction of immune activation with" exact="chloroquine" post="therapy during chronic HIV infectionJ. Virol.201084120821208610.1128/JVI.01466-1020844049 44.RoutyJ.P.AngelJ.B.PatelM.KanagarathamC.RadziochD.KemaI.GilmoreN.AncutaP.SingerJ.JenabianM.A.Assessment of chloroquine"/>
  <result pre="with chloroquine therapy during chronic HIV infectionJ. Virol.201084120821208610.1128/JVI.01466-1020844049 44.RoutyJ.P.AngelJ.B.PatelM.KanagarathamC.RadziochD.KemaI.GilmoreN.AncutaP.SingerJ.JenabianM.A.Assessment of" exact="chloroquine" post="as a modulator of immune activation to improve CD4"/>
  <result pre="A randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly" exact="chloroquine" post="among adults on antiretroviral therapy in Malawi: Study protocol"/>
  <result pre="multidrug-resistant cytomegalovirus diseaseTranspl. Infect. Dis.20151775175510.1111/tid.1243526432076 48.GermiR.MarietteC.AlainS.LupoJ.ThiebautA.BrionJ.P.EpaulardO.Saint RaymondC.MalvezziP.MorandP.Success and failure of" exact="artesunate" post="treatment in five transplant recipients with disease caused by"/>
  <result pre="broad-spectrum antiinfective drug artesunateJ. Clin. Virol.200946242810.1016/j.jcv.2009.05.01719501020 52.HakacovaN.KlingelK.KandolfR.EngdahlE.Fogdell-HahnA.HigginsT.First therapeutic use of" exact="Artesunate" post="in treatment of human herpesvirus 6B myocarditis in a"/>
  <result pre="compounds in HHV-6-infected lymphoblastsJ. Clin. Virol.200637Suppl. S1S69S7510.1016/S1386-6532(06)70015-417276373 54.SharmaB.N.MarschallM.RinaldoC.H.Antiviral effects of" exact="artesunate" post="on JC polyomavirus replication in COS-7 cellsAntimicrob. Agents Chemother.2014586724673410.1128/AAC.03714-1425155602"/>
  <result pre="polyomavirus replication in COS-7 cellsAntimicrob. Agents Chemother.2014586724673410.1128/AAC.03714-1425155602 55.SharmaB.N.MarschallM.HenriksenS.RinaldoC.H.Antiviral effects of" exact="artesunate" post="on polyomavirus BK replication in primary human kidney cellsAntimicrob."/>
  <result pre="Dis.20196ofz25010.1093/ofid/ofz25031281856 61.Arav-BogerR.HeR.ChiouC.J.LiuJ.WoodardL.RosenthalA.Jones-BrandoL.FormanM.PosnerG.Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to" exact="artemisinin" post="monomersPLoS ONE20105e1037010.1371/journal.pone.001037020442781 62.MottB.T.HeR.ChenX.FoxJ.M.CivinC.I.Arav-BogerR.PosnerG.H.Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus"/>
  <result pre="anti-cancer agents: A structure-activity studyBioorg. Med. Chem.2013213702370710.1016/j.bmc.2013.04.02723673218 63.BlazquezA.G.Fernandez-DolonM.Sanchez-VicenteL.MaestreA.D.Gomez-San MiguelA.B.AlvarezM.SerranoM.A.JansenH.EfferthT.MarinJ.J.et al.Novel" exact="artemisinin" post="derivatives with potential usefulness against liver/colon cancer and viral"/>
  <result pre="Role in the treatment of malariaMalar. J.20111014410.1186/1475-2875-10-14421609473 66.MalakarS.SreelathaL.DechtawewatT.NoisakranS.YenchitsomanusP.T.ChuJ.J.H.LimjindapornT.Drug repurposing of" exact="quinine" post="as antiviral against dengue virus infectionVirus Res.201825517117810.1016/j.virusres.2018.07.01830055216 67.SeelerA.O.GraessleO.OttW.H.Effect of"/>
  <result pre="quinine as antiviral against dengue virus infectionVirus Res.201825517117810.1016/j.virusres.2018.07.01830055216 67.SeelerA.O.GraessleO.OttW.H.Effect of" exact="quinine" post="on influenza virus infections in miceJ. Infect. Dis.19467915615810.1093/infdis/79.2.15620273894 68.WolfR.BaroniA.GrecoR.CorradoF.RuoccoE.TufanoM.A.RuoccoV.Quinine"/>
  <result pre="68.WolfR.BaroniA.GrecoR.CorradoF.RuoccoE.TufanoM.A.RuoccoV.Quinine sulfate and HSV replicationDermatol. Online J.200393 69.BaroniA.PaolettiI.RuoccoE.AyalaF.CorradoF.WolfR.TufanoM.A.DonnarummaG.Antiviral effects of" exact="quinine" post="sulfate on HSV-1 HaCat cells infected: Analysis of the"/>
  <result pre="al.Progressive multifocal leukoencephalopathy in common variable immunodeficiency: Mitigated course under" exact="mirtazapine" post="and mefloquineJ. Neurovirol.20152169470110.1007/s13365-015-0340-425916731 96.BalakD.M.W.HajdarbegovicE.BramerW.M.NeumannH.A.M.ThioH.B.Progressive multifocal leukoencephalopathy associated with fumaric"/>
  <result pre="under mirtazapine and mefloquineJ. Neurovirol.20152169470110.1007/s13365-015-0340-425916731 96.BalakD.M.W.HajdarbegovicE.BramerW.M.NeumannH.A.M.ThioH.B.Progressive multifocal leukoencephalopathy associated with" exact="fumaric acid" post="esters treatment in psoriasis patientsJ. Eur. Acad. Dermatol. Venereol.2017311475148210.1111/jdv.1423628322482"/>
  <result pre="Dermatol. Venereol.2017311475148210.1111/jdv.1423628322482 97.YoshidaH.OhshimaK.TodaJ.KusakabeS.MasaieH.YagiT.IshikawaJ.Significant improvement following combination treatment with mefloquine and" exact="mirtazapine" post="in a patient with progressive multifocal leukoencephalopathy after allogeneic"/>
  <result pre="intravenous immunoglobulin in a patient with multiple sclerosis treated with" exact="fingolimod" post="after discontinuation of natalizumabJ. Clin. Neurosci.20152259860010.1016/j.jocn.2014.08.01625523125 99.SilverioK.A.PatelS.A.Progressive Multifocal Leukoencephalopathy"/>
  <result pre="a 44-year old male with idiopathic CD4+ T-lymphocytopenia treated with" exact="mirtazapine" post="and mefloquineNeurol. India2017651061106410.4103/neuroindia.NI_535_1628879898 103.IshikawaY.KasuyaT.IshikawaJ.FujiwaraM.KitaY.A case of developing progressive multifocal"/>
  <result pre="case of developing progressive multifocal leukoencephalopathy while using rituximab and" exact="mycophenolate mofetil" post="in refractory systemic lupus erythematosusTher. Clin. Risk Manag.2018141149115310.2147/TCRM.S16710929983569 104.IkedaK.M.DasS.StrongM.MirsattariS.M.LeungA.StevenD.HammondR.Diagnosis"/>
  <result pre="107.HarelA.HorngS.GustafsonT.RamineniA.FarberR.S.FabianM.Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and" exact="maraviroc" post="in a patient with idiopathic CD4 lymphocytopeniaJ. Neurovirol.20182465265510.1007/s13365-018-0657-x29987583 108.ZhangY.WrightC.FloresA.Asymptomatic"/>
  <result pre="cyclophosphamide graft-versus-host disease prophylaxisTranspl. Infect. Dis.201820e1285010.1111/tid.1285029359846 114.LutzM.SchulzeA.B.RebberE.WiebeS.ZoubiT.GrauerO.M.KeßlerT.KerkhoffA.LenzG.BerdelW.E.Progressive Multifocal Leukoencephalopathy after" exact="Ibrutinib" post="Therapy for Chronic Lymphocytic LeukemiaCancer Res. Treat.20174954855210.4143/crt.2016.11027456945 115.WüthrichC.PopescuB.F.GheuensS.MarviM.ZimanR.DenqS.P.ThamM.NortonE.ParisiJ.E.DangX.et al.Natalizumab-associated"/>
  <result pre="manifestations from malaria to multifarious diseasesJ. Antimicrob. Chemother.2015701608162110.1093/jac/dkv01825693996 136.ShimizuY.YamamotoS.HommaM.IshidaN.Effect of" exact="chloroquine" post="on the growth of animal virusesArch. Gesamte Virusforsch.1972369310410.1007/BF012502994335025 137.InglotA.D.Comparison"/>
  <result pre="138.KhanM.SanthoshS.R.TiwariM.Lakshmana RaoP.V.ParidaM.Assessment of in vitro prophylactic and therapeutic efficacy of" exact="chloroquine" post="against Chikungunya virus in vero cellsJ. Med. Virol.20108281782410.1002/jmv.2166320336760 139.SourisseauM.SchilteC.CasartelliN.TrouilletC.Guivel-BenhassineF.RudnickaD.Sol-FoulonN.Le"/>
  <result pre="SARS coronavirus infection and spreadVirol. J.200526910.1186/1743-422X-2-6916115318 146.KeyaertsE.LiS.VijgenL.RysmanE.VerbeeckJ.Van RanstM.MaesP.Antiviral activity of" exact="chloroquine" post="against human coronavirus OC43 infection in newborn miceAntimicrob. Agents"/>
  <result pre="endocytosisJ. Virol.2006806964697210.1128/JVI.00024-0616809302 149.MizuiT.YamashinaS.TanidaI.TakeiY.UenoT.SakamotoN.IkejimaK.KitamuraT.EnomotoN.SakaiT.et al.Inhibition of hepatitis C virus replication by" exact="chloroquine" post="targeting virus-associated autophagyJ. Gastroenterol.20104519520310.1007/s00535-009-0132-919760134 150.Al-BariM.A.A.Targeting endosomal acidification by chloroquine"/>
  <result pre="by chloroquine targeting virus-associated autophagyJ. Gastroenterol.20104519520310.1007/s00535-009-0132-919760134 150.Al-BariM.A.A.Targeting endosomal acidification by" exact="chloroquine" post="analogs as a promising strategy for the treatment of"/>
  <result pre="Retrovir.1990648148910.1089/aid.1990.6.4811692728 152.SperberK.KalbT.H.StecherV.J.BanerjeeR.MayerL.Inhibition of human immunodeficiency virus type 1 replication by" exact="hydroxychloroquine" post="in T cells and monocytesAIDS Res. Hum. Retrovir.19939919810.1089/aid.1993.9.918427717 153.ChiangG.SassaroliM.LouieM.ChenH.StecherV.J.SperberK.Inhibition"/>
  <result pre="anti-HIV-1 activity of chloroquineJ. Clin. Virol.20012013113510.1016/S1386-6532(00)00139-611166661 155.BoelaertJ.R.PietteJ.SperberK.The potential place of" exact="chloroquine" post="in the treatment of HIV-1-infected patientsJ. Clin. Virol.20012013714010.1016/S1386-6532(00)00140-211166662 156.SavarinoA.LuciaM.B.RastrelliE.RutellaS.GolottaC.MorraE.TamburriniE.PernoC.F.BoelaertJ.R.SperberK.et"/>
  <result pre="synergism with protease inhibitorsJ. Acquir. Immune. Defic. Syndr.20043522323210.1097/00126334-200403010-0000215076236 157.NaardingM.A.BaanE.PollakisG.PaxtonW.A.Effect of" exact="chloroquine" post="on reducing HIV-1 replication in vitro and the DC-SIGN"/>
  <result pre="for human PSGL-1-mediated enterovirus 71 infectionJ. Virol.2013879064907610.1128/JVI.00573-1323760234 161.TanY.W.YamW.K.SunJ.ChuJ.J.H.An evaluation of" exact="Chloroquine" post="as a broad-acting antiviral against Hand, Foot and Mouth"/>
  <result pre="NucleotidesJ. Virol.20199310.1128/JVI.00389-1930894466 167.CastelliF.OdoliniS.AutinoB.FocaE.RussoR.Malaria Prophylaxis: A Comprehensive ReviewPharmaceuticals201033212323910.3390/ph3103212 168.RothanH.A.MohamedZ.PaydarM.RahmanN.A.YusofR.Inhibitory effect of" exact="doxycycline" post="against dengue virus replication in vitroArch. Virol.201415971171810.1007/s00705-013-1880-724142271 169.RothanH.A.BahraniH.MohamedZ.TeohT.C.ShankarE.M.RahmanN.A.YusofR.A combination"/>
  <result pre="against dengue virus replication in vitroArch. Virol.201415971171810.1007/s00705-013-1880-724142271 169.RothanH.A.BahraniH.MohamedZ.TeohT.C.ShankarE.M.RahmanN.A.YusofR.A combination of" exact="doxycycline" post="and ribavirin alleviated chikungunya infectionPLoS ONE201510e012636010.1371/journal.pone.012636025970853 170.WuZ.C.WangX.WeiJ.C.LiB.B.ShaoD.H.LiY.M.LiuK.ShiY.Y.ZhouB.QiuY.F.et al.Antiviral activity"/>
  <result pre="virus replication in vitroArch. Virol.201415971171810.1007/s00705-013-1880-724142271 169.RothanH.A.BahraniH.MohamedZ.TeohT.C.ShankarE.M.RahmanN.A.YusofR.A combination of doxycycline and" exact="ribavirin" post="alleviated chikungunya infectionPLoS ONE201510e012636010.1371/journal.pone.012636025970853 170.WuZ.C.WangX.WeiJ.C.LiB.B.ShaoD.H.LiY.M.LiuK.ShiY.Y.ZhouB.QiuY.F.et al.Antiviral activity of doxycycline"/>
  <result pre="and ribavirin alleviated chikungunya infectionPLoS ONE201510e012636010.1371/journal.pone.012636025970853 170.WuZ.C.WangX.WeiJ.C.LiB.B.ShaoD.H.LiY.M.LiuK.ShiY.Y.ZhouB.QiuY.F.et al.Antiviral activity of" exact="doxycycline" post="against vesicular stomatitis virus in vitroFEMS Microbiol. Lett.201536210.1093/femsle/fnv195 171.NgH.H.NarasarajuT.PhoonM.C.SimM.K.SeetJ.E.ChowV.T.Doxycycline"/>
  <result pre="metalloproteinasesExp. Mol. Pathol.20129228729510.1016/j.yexmp.2012.03.00322421441 172.ZhuJ.LiuS.LiuZ.LiY.TianJ.HuX.A highly sensitive and selective assay of" exact="doxycycline" post="by dualwavelength overlapping resonance Rayleigh scatteringSpectrochim. Acta A Mol."/>
  <result pre="liver transplantationTranspl. Infect. Dis.20121432632910.1111/j.1399-3062.2011.00709.x22260451 174.WalterM.S.FrankM.J.SatuéM.MonjoM.RønoldH.J.LyngstadaasS.P.HaugenH.J.Bioactive implant surface with electrochemically bound" exact="doxycycline" post="promotes bone formation markers in vitro and in vivoDent."/>
  <result pre="on 15 December 2019) 176.BriolantS.WurtzN.ZettorA.RogierC.PradinesB.Susceptibility of Plasmodium falciparum isolates to" exact="doxycycline" post="is associated with pftetQ sequence polymorphisms and pftetQ and"/>
  <result pre="cell linesCan. J. Physiol. Pharmacol.20169452653310.1139/cjpp-2015-048126913972 178.YangJ.M.ChenY.F.TuY.Y.YenK.R.YangY.L.Combinatorial computational approaches to identify" exact="tetracycline" post="derivatives as flavivirus inhibitorsPLoS ONE20072e42810.1371/journal.pone.000042817502914 179.BhattacharjeeM.K.Antimetabolites: Antibiotics That Inhibit"/>
  <result pre="replication of human herpesvirus 8 in microvascular endothelial cells by" exact="alpha" post="interferon and phosphonoformic acidJ. Virol.2004788359837110.1128/JVI.78.15.8359-8371.200415254208 186.TselisA.Evidence for viral etiology"/>
  <result pre="for the evaluation of antiviral agentsAntivir. Res.20036011510.1016/S0166-3542(03)00174-814516916 188.RomeroM.R.SerranoM.A.VallejoM.EfferthT.AlvarezM.MarinJ.J.Antiviral effect of" exact="artemisinin" post="from Artemisia annua against a model member of the"/>
  <result pre="Virus Family Virus Species Drug Trial Number/Reference Outcome Herpesviridae HCMV" exact="Artesunate" post="NCT00284687 No results Papillomaviridae HPV Artesunate NCT03100045 Ongoing NCT04098744"/>
  <result pre="Number/Reference Outcome Herpesviridae HCMV Artesunate NCT00284687 No results Papillomaviridae HPV" exact="Artesunate" post="NCT03100045 Ongoing NCT04098744 Ongoing Flaviviridae HCV Hydroxychloroquine NCT01833845 Terminated"/>
  <result pre="results Papillomaviridae HPV Artesunate NCT03100045 Ongoing NCT04098744 Ongoing Flaviviridae HCV" exact="Hydroxychloroquine" post="NCT01833845 Terminated due to failure to recruit subjects NCT01272310"/>
  <result pre="Terminated due to failure to recruit subjects NCT01272310 Unknown DENV" exact="Chloroquine" post="NCT00849602 Reduction in pain but not in length of"/>
  <result pre="in pain but not in length of disease [36] CHIKV" exact="Chloroquine" post="NCT003913131 No difference between CQ- and placebo-treated groups [37]"/>
  <result pre="No difference between CQ- and placebo-treated groups [37] Orthomyxoviridae IAV" exact="Chloroquine" post="NCT01078779 No prevention of IAV infection [38] Retroviridae HIV"/>
  <result pre="Chloroquine NCT01078779 No prevention of IAV infection [38] Retroviridae HIV" exact="Hydroxychloroquine" post="[39,40] Reduction in HIV-1 RNA load in plasma Hydroxychloroquine"/>
  <result pre="HIV Hydroxychloroquine [39,40] Reduction in HIV-1 RNA load in plasma" exact="Hydroxychloroquine" post="ISRCTN30019040 Increased HIV-1 replication and decreased CD4 numbers [41]"/>
  <result pre="Hydroxychloroquine ISRCTN30019040 Increased HIV-1 replication and decreased CD4 numbers [41]" exact="Chloroquine" post="NCT00819390 Modest reduction in immune activation [42] Chloroquine NCT02004314"/>
  <result pre="numbers [41] Chloroquine NCT00819390 Modest reduction in immune activation [42]" exact="Chloroquine" post="NCT02004314 Patients did not experience any improvement after CQ"/>
  <result pre="Patients did not experience any improvement after CQ treatment [43]" exact="Chloroquine" post="NCT01650558 Terminated, awaiting results [44,45] microorganisms-08-00085-t002_Table 2Table 2 Clinical"/>
  <result pre="Mefloquine No PML progression [72,73,74,77,78,79,81,82,83,84,86,87] Fatal outcome [75,76,80,85,88] Mefloquine +" exact="mirtazapine" post="PML resolution with claimed effects [86,87,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105] PML resolution due"/>
  <result pre="[87,96,110,111,112,113,114,115,116] Therapy suspension due to side effects [117] Mefloquine +" exact="mirtazapine" post="+ third partner drug PML resolution [118] Fatal outcome"/>
  <result pre="partner drug PML resolution [118] Fatal outcome [119] Mefloquine +" exact="risperidone" post="Fatal outcome [75] Mefloquine + risperidone + cytarabine PML"/>
  <result pre="outcome [119] Mefloquine + risperidone Fatal outcome [75] Mefloquine +" exact="risperidone" post="+ cytarabine PML resolution [120] Mefloquine + cidofovir PML"/>
  <result pre="Mefloquine + risperidone Fatal outcome [75] Mefloquine + risperidone +" exact="cytarabine" post="PML resolution [120] Mefloquine + cidofovir PML resolution due"/>
  <result pre="Mefloquine + risperidone + cytarabine PML resolution [120] Mefloquine +" exact="cidofovir" post="PML resolution due to other factors [121] HIV positive"/>
  <result pre="Mefloquine No PML progression [122,123,124,125] Fatal outcome [126] Mefloquine +" exact="mirtazapine" post="Premature fatal outcome [127,128] Clinical Trial HIV negative versus"/>
  <result pre="Virus Species Drug Type of Study (Model) References Herpesviridae HSV-1" exact="Quinine" post="sulfate in vivo [68,69] EBV Artesunate in vitro [50]"/>
  <result pre="(Model) References Herpesviridae HSV-1 Quinine sulfate in vivo [68,69] EBV" exact="Artesunate" post="in vitro [50] Sulfonamides in vitro [182] HCMV Artemisinin"/>
  <result pre="EBV Artesunate in vitro [50] Sulfonamides in vitro [182] HCMV" exact="Artemisinin" post="in vitro [16] Artesunate in vitro [10,11,16,17,24,25,26,27,28,29,30,31,32,33,34] Arthemeter in"/>
  <result pre="[50] Sulfonamides in vitro [182] HCMV Artemisinin in vitro [16]" exact="Artesunate" post="in vitro [10,11,16,17,24,25,26,27,28,29,30,31,32,33,34] Arthemeter in vitro [61,62] HHV-6 Artesunate"/>
  <result pre="[16] Artesunate in vitro [10,11,16,17,24,25,26,27,28,29,30,31,32,33,34] Arthemeter in vitro [61,62] HHV-6" exact="Artesunate" post="in vitro [51,53] HHV-6B Artesunate in vitro [52] KSHV"/>
  <result pre="Arthemeter in vitro [61,62] HHV-6 Artesunate in vitro [51,53] HHV-6B" exact="Artesunate" post="in vitro [52] KSHV Doxycycline in vitro [183] HSE"/>
  <result pre="Artesunate in vitro [51,53] HHV-6B Artesunate in vitro [52] KSHV" exact="Doxycycline" post="in vitro [183] HSE Artemisinin in vivo (mouse) [35]"/>
  <result pre="Artesunate in vitro [52] KSHV Doxycycline in vitro [183] HSE" exact="Artemisinin" post="in vivo (mouse) [35] Dihydroartemisinin in vitro [16] KSHV"/>
  <result pre="Dihydroartemisinin in vitro [16] KSHV Sulfonamides in vitro [183] RCMV" exact="Artesunate" post="in vivo (rat) [11] Polyomaviridae BKPyV Artesunate in vitro"/>
  <result pre="vitro [183] RCMV Artesunate in vivo (rat) [11] Polyomaviridae BKPyV" exact="Artesunate" post="in vitro [55] JCPyV Artesunate in vitro [54] Mefloquine"/>
  <result pre="vivo (rat) [11] Polyomaviridae BKPyV Artesunate in vitro [55] JCPyV" exact="Artesunate" post="in vitro [54] Mefloquine in vitro [71] Hepadnaviridae HBV"/>
  <result pre="in vitro [54] Mefloquine in vitro [71] Hepadnaviridae HBV Artemisinin," exact="artesunate" post="in vitro [17] Papillomaviridae HPV Artemisinin in vitro [18]"/>
  <result pre="[71] Hepadnaviridae HBV Artemisinin, artesunate in vitro [17] Papillomaviridae HPV" exact="Artemisinin" post="in vitro [18] Dihydroartemisinin in vivo (dog) [19] Doxycycline"/>
  <result pre="HPV Artemisinin in vitro [18] Dihydroartemisinin in vivo (dog) [19]" exact="Doxycycline" post="in vitro [177] Flaviviridae BVDV(surrogate HCV) Artemisinin in vitro"/>
  <result pre="vivo (dog) [19] Doxycycline in vitro [177] Flaviviridae BVDV(surrogate HCV)" exact="Artemisinin" post="in vitro [187,188] Dihydroartemisinin in vitro [63] HCV Artemisinin"/>
  <result pre="HCV) Artemisinin in vitro [187,188] Dihydroartemisinin in vitro [63] HCV" exact="Artemisinin" post="in vitro [20,21,22] Artesunate in vitro [57] Chloroquine in"/>
  <result pre="[187,188] Dihydroartemisinin in vitro [63] HCV Artemisinin in vitro [20,21,22]" exact="Artesunate" post="in vitro [57] Chloroquine in vitro [148,149,150] ZIKV Mefloquine"/>
  <result pre="[63] HCV Artemisinin in vitro [20,21,22] Artesunate in vitro [57]" exact="Chloroquine" post="in vitro [148,149,150] ZIKV Mefloquine in vitro [130,131] Chloroquine"/>
  <result pre="[57] Chloroquine in vitro [148,149,150] ZIKV Mefloquine in vitro [130,131]" exact="Chloroquine" post="in vitro [140,141] Amodiaquine in vitro [140] Atovaquone in"/>
  <result pre="vitro [130,131] Chloroquine in vitro [140,141] Amodiaquine in vitro [140]" exact="Atovaquone" post="in vitro [166] DENV Quinine sulfate in vitro [66]"/>
  <result pre="[140,141] Amodiaquine in vitro [140] Atovaquone in vitro [166] DENV" exact="Quinine" post="sulfate in vitro [66] Mefloquine in vitro [131] Halofantrine"/>
  <result pre="vitro [66] Mefloquine in vitro [131] Halofantrine in vitro [134]" exact="Doxycycline" post="in vitro [168,178] Amodiaquine in vitro [162] CHIKV Doxycycline"/>
  <result pre="[134] Doxycycline in vitro [168,178] Amodiaquine in vitro [162] CHIKV" exact="Doxycycline" post="in vitro [169] Chloroquine in vitro [37,138,139] Atovaquone in"/>
  <result pre="[168,178] Amodiaquine in vitro [162] CHIKV Doxycycline in vitro [169]" exact="Chloroquine" post="in vitro [37,138,139] Atovaquone in vitro [166] Togaviridae SFV"/>
  <result pre="[162] CHIKV Doxycycline in vitro [169] Chloroquine in vitro [37,138,139]" exact="Atovaquone" post="in vitro [166] Togaviridae SFV Halofantrine in vitro [134]"/>
  <result pre="vitro [166] Togaviridae SFV Halofantrine in vitro [134] Rhabdoviridae VSV" exact="Doxycycline" post="in vitro [170] Orthomyxoviridae IAV Quinine sulfate in vitro"/>
  <result pre="vitro [134] Rhabdoviridae VSV Doxycycline in vitro [170] Orthomyxoviridae IAV" exact="Quinine" post="sulfate in vitro [70] In vivo (mouse) [67] Mefloquine"/>
  <result pre="vitro [70] In vivo (mouse) [67] Mefloquine in vitro [70]" exact="Doxycycline" post="in vivo (mouse) [171] Chloroquine in vitro [159] Coronaviridae"/>
  <result pre="[67] Mefloquine in vitro [70] Doxycycline in vivo (mouse) [171]" exact="Chloroquine" post="in vitro [159] Coronaviridae CoV Chloroquine in vitro [145,146,147]"/>
  <result pre="in vivo (mouse) [171] Chloroquine in vitro [159] Coronaviridae CoV" exact="Chloroquine" post="in vitro [145,146,147] Picornaviridae Enteroviruses Chloroquine in vitro [160]"/>
  <result pre="vitro [159] Coronaviridae CoV Chloroquine in vitro [145,146,147] Picornaviridae Enteroviruses" exact="Chloroquine" post="in vitro [160] Chloroquine in vitro/in vivo (mouse) [161]"/>
  <result pre="Chloroquine in vitro [145,146,147] Picornaviridae Enteroviruses Chloroquine in vitro [160]" exact="Chloroquine" post="in vitro/in vivo (mouse) [161] Filoviridae EBOV Chloroquine in"/>
  <result pre="vitro [160] Chloroquine in vitro/in vivo (mouse) [161] Filoviridae EBOV" exact="Chloroquine" post="in vitro [142,143] in vivo [142] Artesunate, amodiaquine in"/>
  <result pre="amodiaquine in vivo [58] Mefloquine in vitro [132] Retroviridae HIV" exact="Artemisinin" post="in vitro [23] Doxycycline in vitro [23] Mefloquine, toremifene,"/>
  <result pre="Mefloquine in vitro [132] Retroviridae HIV Artemisinin in vitro [23]" exact="Doxycycline" post="in vitro [23] Mefloquine, toremifene, posaconazole in vitro [132]"/>
  <result pre="Artemisinin in vitro [23] Doxycycline in vitro [23] Mefloquine, toremifene," exact="posaconazole" post="in vitro [132] Chloroquine in vitro [151,157,158] in vivo"/>
  <result pre="Doxycycline in vitro [23] Mefloquine, toremifene, posaconazole in vitro [132]" exact="Chloroquine" post="in vitro [151,157,158] in vivo [155] Chloroquine, hydroxychloroquine in"/>
  <result pre="vitro [132] Chloroquine in vitro [151,157,158] in vivo [155] Chloroquine," exact="hydroxychloroquine" post="in vitro [152,153,154,156] Phenuiviridae SFTSV Amodiaquine In vitro [163]"/>
  <result pre="viral infection. Virus Family Virus Species Drug References Herpesviridae HCMV" exact="Artesunate" post="[12,13,46,47,48] Artesunate-amodiaquine [49] Arthemeter-lumefantrine [64] HHV6 Artesunate [52] Polyomaviridae"/>
  <result pre="References Herpesviridae HCMV Artesunate [12,13,46,47,48] Artesunate-amodiaquine [49] Arthemeter-lumefantrine [64] HHV6" exact="Artesunate" post="[52] Polyomaviridae JCPyV Artesunate [54,55] Mefloquine [72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,122,123,124,125,126] Mefloquine and"/>
  <result pre="[12,13,46,47,48] Artesunate-amodiaquine [49] Arthemeter-lumefantrine [64] HHV6 Artesunate [52] Polyomaviridae JCPyV" exact="Artesunate" post="[54,55] Mefloquine [72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,122,123,124,125,126] Mefloquine and mirtazapine [86,87,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,127,128] Mefloquine, mirtazapine"/>
  <result pre="Artesunate [52] Polyomaviridae JCPyV Artesunate [54,55] Mefloquine [72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,122,123,124,125,126] Mefloquine and" exact="mirtazapine" post="[86,87,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,127,128] Mefloquine, mirtazapine and a third drug [118,119] Mefloquine"/>
  <result pre="JCPyV Artesunate [54,55] Mefloquine [72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,122,123,124,125,126] Mefloquine and mirtazapine [86,87,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,127,128] Mefloquine," exact="mirtazapine" post="and a third drug [118,119] Mefloquine and risperidone [75]"/>
  <result pre="[86,87,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,127,128] Mefloquine, mirtazapine and a third drug [118,119] Mefloquine and" exact="risperidone" post="[75] Mefloquine, risperidone and cytarabine [120] Mefloquine and cidofovir"/>
  <result pre="and a third drug [118,119] Mefloquine and risperidone [75] Mefloquine," exact="risperidone" post="and cytarabine [120] Mefloquine and cidofovir [121] Mefloquine and"/>
  <result pre="third drug [118,119] Mefloquine and risperidone [75] Mefloquine, risperidone and" exact="cytarabine" post="[120] Mefloquine and cidofovir [121] Mefloquine and PML standard"/>
  <result pre="and risperidone [75] Mefloquine, risperidone and cytarabine [120] Mefloquine and" exact="cidofovir" post="[121] Mefloquine and PML standard of care [129] Filoviridae"/>
 </snippets>
</snippetsTree>
